Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2

Hrstka, Roman; Murray, Euan; Brychtova, Veronika; Fabian, Pavel; Hupp, Ted R.; Vojtesek, Borivoj

Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2

2013

The pro-metastatic protein anterior gradient-2 (AGR2) was previously demonstrated as a predictive factor of poor response to tamoxifen treatment. In this study we aimed to delineate the key signalling pathway that may contribute to regulation of AGR2 protein induction in order to identify novel targets to overcome tamoxifen resistance in tumour cells. Together, our data identify PDPK1-AKT as a pro-oncogenic signalling pathway that triggers AGR2 protein induction in response to tamoxifen and suggest that AKT inhibitors could be used as part of a therapeutic strategy to treat tamoxifen resistant, AGR2 over-expressing cancers.

Afficher plus [+]

Mots clés AGROVOC

antineoplastic agents drug resistance drug therapy genetics humans metabolism neoplasms pathology pharmacology proteins proteins ribonucleosides serine

Informations bibliographiques

Publié dans

Cancer letters

ISSN 0304-3835

Editeur

Elsevier B.V.

D'autres materias

Drug effects; Proto-oncogene proteins c-akt; Cell line; Tumor; Base sequence; Micrornas; Signal transduction; 3-phosphoinositide-dependent protein kinases; Breast neoplasms; Tamoxifen; Protein serine-threonine kinases; Molecular sequence data; Female; Tamoxifen; Hormonal; Signal transduction

Langue

anglais

Type

Journal Article; Text

Sur AGRIS depuis: 2024-02-27

Format: MODS

Fournisseur de données

Cette notice bibliographique a été fournie par National Agricultural Library

Découvrez la collection de ce fournisseur de données dans AGRIS

Liens

DOI http://dx.doi.org/10.1016/j.canlet.2013.01.034

Consulter Google Scholar